Literature DB >> 12930735

Bcr-Abl mutations, resistance to imatinib, and imatinib plasma levels.

Carlo Gambacorti-Passerini, Rocco Piazza, Maurizio D'Incalci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12930735     DOI： 10.1182/blood-2003-05-1629

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  Expanding the portfolio of anti-ALK weapons.

Authors:  Luca Mologni
Journal:  Transl Lung Cancer Res       Date:  2015-02

2.  Nilotinib based pharmacophore models for BCRABL.

Authors:  Kesavan Sabitha
Journal:  Bioinformation       Date:  2012-07-21

3.  Two different point mutations in ABL gene ATP-binding domain conferring Primary Imatinib resistance in a Chronic Myeloid Leukemia (CML) patient: A case report.

Authors:  Zafar Iqbal; Rubina T. Siddiqui; Javed A. Qureshi
Journal:  Biol Proced Online       Date:  2004-07-01       Impact factor: 3.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.